We are pleased to announce that Andrea Sadlonova is joining our team as Head of clinical and regulatory affairs as of January 2026. Andrea has a PhD degree in molecular and cellular pathology from University of Alabama in Birmingham (AL, USA). She brings to our company a very valuable experience gained during her post-doctoral fellowship in immunology at the Emory University in Atlanta (Georgia, USA), as well as during her work in development, quality, regulatory and clinical affairs for numerous pharmaceutical companies such as PPF/SOTIO (USA – CZ), Saneca Pharmaceuticals (SVK), ImunomedicA (CZ) etc.

We look forward to creating together a world, where cancer will be diagnosed early and treated successfully!